Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.1208
Delayed Data
As of 3:59pm ET
 +0.0049 / +4.23%
Today’s Change
0.07
Today|||52-Week Range
0.71
+39.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues0.000.0045.0K83.0K
 
 
 
Depreciation And Amortization32.0K30.0K24.0K13.0K
 
 
 
 
 
 
Operating ExpensesGross Income-32.0K-30.0K----
 
 
 
General Expenses10.7M10.2M7.2M1.7M
 
 
 
 
 
Research And Development7.9M7.8M5.1M78.0K
 
 
 
 
 
Total Operating Expenses10.7M10.2M7.2M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-10.2M-7.2M-1.6M
 
 
 
 
 
Extraordinary Charge0.000.000.00-6.7M
 
 
Interest Expense On Debt519.0K512.0K948.0K153.0K
 
 
 
 
 
Other Expenses15.0K-9.0K-34.0K-14.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.2M-10.7M-8.2M-8.4M
 
 
 
 
 
Income Taxes0.000.000.00-2.4M
 
 
Net Income-11.2M-10.7M-8.2M-6.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS178.1M196.6M214.7M244.1M
 
 
 
 
 
Shares To Calculate EPS Diluted178.1M196.6M214.7M244.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.05-$0.04-$0.02
 
 
 
 
 
EPS Diluted-$0.06-$0.05-$0.04-$0.02